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T he colon, as a barrier tissue, represents a unique immune environment where immune cells display tolerance toward a diverse community of microbes, which are collectively known as the microbiome. The microbiome is critical for many aspects of health and an imbalance of commensals and pathogenic microbes is linked with many disease states 1 . Thus, understanding what constitutes a healthy, homeostatic relationship between host immune cells and the microbiome of the human colon is of critical importance.
The composition of the microbiota at any location in the intestines is determined by the availability of nutrients and oxygen, the transit rate of luminal content and compartmentalized host immune activity; as such, it is spatially distinct 2 . Regional differences are most evident when comparing the small intestine and distal colon in humans or other mammals 2 . Within the colon, increasing bacterial diversity from proximal (including the cecum, ascending colon and transverse colon) to distal regions (comprising the descending and sigmoid colon connecting to the rectum) has been reported 3 . The intestinal immune system has a symbiotic relationship with the microbiome and is central to the maintenance of epithelial barrier integrity. The lamina propria and associated lymphoid tissues contain one of the largest and most diverse communities of immune cells, which includes both lymphocytes and myeloid cells 4 . There is marked regional variation in immune cells along the gastrointestinal tract, with type 17 helper T cells (T H 17) decreasing in number from the duodenum to the colon, and regulatory T cell (T reg ) numbers being highest in the colon 5 . Immune cells can respond to environmental cues, including the microbiota. Mouse studies have demonstrated that specific bacterial species can fine-tune intestinal immune responses, including T H 17 (refs. 6,7 ), T reg 8 or T H 1 (refs. 9, 10 ) and B cell activation 11 . However, the extent to which there is regional variation in the mucosal microbiome within an individual and how this might influence local immune cell niches along the colon, has not been investigated to date.
In this study, we cataloged the mucosal microbiome in different regions of the human colon, a gastrointestinal organ with the most diverse and dense microbiome content and region-restricted disease states 2 . In parallel, we applied single-cell RNA sequencing (scRNA-seq) to carry out a census of steady-state immune cell populations in the adjacent tissue and in draining mesenteric lymph nodes (MLNs), the results of which are available at the Gut Cell Atlas (https://www.gutcellatlas.org/). We demonstrate previously unappreciated changes in the proportions and activation status of T and B cells in distinct regions of the healthy human colon from proximal to distal and relate these differences to the changing microbiota.
Results

Microbiome composition differs along distinct colon regions.
To create a map of bacterial composition at the mucosal surface of the colon, we performed 16S ribosomal RNA (16S rRNA) sequencing of swabs from the mucosal surface of the cecum, transverse colon and sigmoid colon of 12 disease-free deceased transplant donors of European ancestry (Methods, Fig. 1a and Supplementary Table 1 ). The major gut phyla-Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria-were present throughout the gut of each donor ( Fig. 1b and Supplementary Table 2 ). While diversity of operational taxonomic units (OTUs) was consistent across the colon and considerable variability existed between donors as reported previously 12 ( Supplementary Fig. 1a ), we observed changes in the composition of the microbiome. Most notably at the level of phyla, Bacteroidetes was more prevalent in the sigmoid colon ( Fig. 1c and Supplementary Fig. 1b ). This was mostly attributable to an increase in Bacteroides, which dominates the colonic microbiome CD19  MS4A1  CD40  IGHD  PRDM1  TNFRSF13B  TCL1A  CXCR5  FCER2  POU2AF1  IGHA1  IGHG1  SDC1  CD38  CD3D  CD4  ICOS  CXCR3  IFNG  CCR6  IL22  FOXP3  CD8A  TRDC  IL7R  ID2  KLRD1  NCR1  FCGR3A  KIT  TPSB2  TPSAB1  HLA-DRA  CD14  MS4A2  LYVE1  ITGAX  XCR1  CLEC9A  CLEC10A  IRF4  SELL  CCR7  MKI67 of individuals on high-protein and high-fat diets typical of Western countries 13 ( Fig. 1c and Supplementary Fig. 1c ). Additionally, Enterococcus was more prevalent in the proximal colon and Coprobacillus and Escherichia/Shigella were more abundant in the distal colon, although these proportions varied considerably between donors (Fig. 1b,c and Supplementary Fig. 1c ). Past studies characterizing the colonic microbiome typically relied on stool samples, which do not accurately recapitulate the composition of bacteria at the mucosal surface 14 . Our catalog of mucosal bacteria throughout the colon demonstrates heterogeneity in the microbiome at the mucosal surface, from the proximal to the distal colon, and reveals specific genera with preference for colonizing certain colon regions.
Immune cell heterogeneity in the steady-state colon. Next, we sought to determine whether the heterogeneity we observed in the colonic microbiome was accompanied by differences in the adjacent host immune cells. To this end, we generated high-quality transcriptional data from over 41,000 single immune cells from the MLNs and lamina propria of the cecum, transverse colon and sigmoid colon ( Fig. 1a ). We acquired tissue biopsies from five deceased transplant donors (Methods and Supplementary Table 1 ). Samples were dissociated to release cells from the MLNs and lamina propria of colonic tissue. Immune cells were enriched either by flow-sorting of CD4 + T cells (live CD45 + CD3 + CD4 + ) and other immune cells (live CD45 + CD3 − CD4 − ), or by CD45 + magnetic bead selection or Ficoll gradient (Methods and Supplementary Fig. 2a ). Each fraction was then subjected to scRNA-seq ( Fig. 1a ). Despite the enrichment for immune cells, we captured epithelial cells and fibroblasts, and these were computationally removed from further analysis (Methods).
Pooled analysis and visualization with uniform manifold approximation and projection (UMAP) of all four tissues from all donors revealed distinct clusters in the lymphoid and colonic tissues ( Fig. 2a and Supplementary Fig. 2b ). We identified 25 cell types and states in the intestinal lamina propria and MLNs ( Fig. 2a , Supplementary  Table 3 and Supplementary Table 4 ), consistent with the immune populations described in recent reports 15 . Among these were follicular and memory B cells, IgA + and IgG + plasma cells, effector and memory CD4 + T cells, T reg cells, CD8 + T cells, γδ T cells, innate lymphoid cells, natural killer cells, mast cells and myeloid cells ( Fig. 2a ). Subclustering of myeloid cells showed two distinct populations of conventional dendritic cells: conventional type 1 dendritic cells (cDC1s) expressing XCR1, CADM1, CLEC9A, BATF3 and IDO1; and conventional type 2 dendritic cells (cDC2s) expressing CLEC10A and CD86 ( Fig. 2a,b ). In addition, we identified monocytes expressing CD14 and CD68, macrophages expressing FCGR3A (the gene encoding CD16), LYVE1 + macrophages 16 and plasmacytoid dendritic cells (pDCs) expressing IRF4 and SELL. B cells, dendritic cells and γδ T cells had MKI67 + cycling populations suggesting higher rates of proliferation compared to other colonic immune cell populations ( Fig. 2a,b ).
To determine how immune cells differ along the colon from proximal to distal regions, we investigated the relative proportions of cell types within the MLNs and colon regions ( Fig. 2c,d ). Since CD4 + T cells and all other immune cells were sorted separately during the initial tissue processing, our analyses were also kept separate. As noted from our visual inspection of the UMAP plot ( Fig. 2a ), there were major differences in the cell types present between MLNs and the colon. There were marked differences in the activation and memory status of T and B cells between the colon and lymph nodes, suggesting that these cell types are molded by their environment (Fig. 2c,d ). In the MLNs, CD4 + T cells were typically CXCR5 + and ICOS hi follicular helper T (T FH ) cells, and SELL + (the gene encoding CD62L) and CCR7 + central memory T (T CM ) cells (Fig. 2b,c) . In contrast, colonic CD4 + T cells had a more effector phenotype, expressing high levels of the tissue residency marker CD69 (ref. 17 ), falling into the T H 17 (CCR6 + , IL22 + , CCL20 + ) or T H 1 (CXCR3 + , IFNG + ) subtypes. There was an inverted gradient in the relative proportion of T H 17 and T H 1 cells, with the cecum dominated by T H 17 cells that reduced in frequency in the transverse colon and still further in the sigmoid colon; T H 1 cells followed the opposite trend, being more abundant in the sigmoid colon ( Fig. 2c ). This distinct distribution of colonic T H 1 and T H 17 cells is concordant with spatial variation of the microbiome, hinting at a relationship between the two populations.
B cells in the MLNs were predominantly CD19 + , MS4A1 + (gene encoding CD20), CD40 + , TNFRSF13B + (gene encoding TACI), CD38 − memory or CXCR5 + , TCL1A + , FCER2 + (gene encoding CD23) follicular B cells ( Fig. 2b,d ). In contrast, in the three regions of the colon, the main population of B cells were SDC1 + (gene encoding CD138), CD38 + plasma cells. Plasma cells were enriched in the sigmoid colon relative to both the cecum and transverse colon, whereas the proportion of memory B cells was lower in the sigmoid colon ( Fig. 2d ). This suggests that conditions in the sigmoid colon may favor the generation of plasma cells rather than memory B cells from germinal center responses in this region, or that the tissue contains more plasma cell niches.
Helper T cells disseminate through the colon and adopt regionspecific transcriptional profiles. We next investigated CD4 + effector T cells across the colon. These were annotated based on the expression of functional markers (IL17A, IL22 and CCL20 versus IFNG and CXCR3) ( Supplementary Fig. 3a ) rather than transcriptional regulators (RORC and TBX21) that are lowly expressed. Correlation analysis of T H 1 and T H 17 cells between different colon tissues revealed high transcriptional similarity between these effector cell subtypes ( Fig. 3a) , with MLN versus peripheral tissue signatures accounting for the greatest amount of variability (Spearman's ρ = 0.88). Within the effector T cells of the colon, transverse colon and cecum cells cluster by helper T cell subtype. T H 1 and T H 17 cells of the sigmoid colon did not cluster with their respective effector subtypes from other regions. Differential gene expression analysis between the effector cells in the sigmoid colon versus those in cecum and transverse colon revealed higher expression of activation-related molecules including TANK (TRAF family member associated NFkB activator; adjusted P < 10 −10 ), CD83 (adjusted P < 10 −10 ) and PIM3 (adjusted P < 10 −8 ) ( Fig. 3b ). Expression of CCL20, which encodes the ligand for CCR6 that is expressed by epithelial and myeloid cells more highly in the small intestine than the colon 18 , was also slightly increased by helper T cells of the proximal colon ( Fig. 3b ), although this is probably due to higher abundance of CCL20 + T H 17 cells at this site ( Fig. 2c and Supplementary Fig. 3a ). Conversely, sigmoid colon effector T cells showed higher expression of KLF2 (adjusted P < 10 −14 ; Fig. 3b ), which encodes a transcriptional factor that transactivates the promoter for sphingosine 1-phosphate receptor 1 and is critical for T cell recirculation through peripheral lymphoid tissue 19 , LMNA (adjusted P < 10 −47 ), which encodes a molecule that is reported to promote T H 1 differentiation 20 , and EEF1G (adjusted P < 10 −13 ), which encodes a driver of protein synthesis.
Next, we investigated the clonal relationships between helper T cells. We performed plate-based Smart-Seq2 on T cell receptor (TCR) α/β + flow-sorted cells from the colonic regions and MLNs of a sixth donor to capture paired gene expression and TCR sequences from individual T cells. Clonal groups were shared between the T H 1 and T H 17 subtypes, supporting the notion that the effector fate of CD4 + T cells is determined after their initial activation 21 (Fig. 3c,d) . Additionally, clonal expansion was observed in the T H 1 cells of the sigmoid colon ( Fig. 3d ), in line with greater abundance in this tissue. Likewise, clonal expansion of T H 17 cells was greatest in the cecum, matching the accumulation seen with the droplet-based scRNA-seq analysis (Fig. 3d ). Several T H 1 and T H 17 clonal sisters were shared between clonal sites ( Fig. 3d ), evidence that helper T cell clones disseminate to distant regions of the colon.
Together these data demonstrate region-specific transcriptional differences relating to activation and tissue migration in T H 1 and T H 17 cells of the proximal and sigmoid colon. Identification of clonal sharing between these colon regions supports the idea that these observed transcriptional differences are due to cell-extrinsic rather than cell-intrinsic factors. Activation trajectory of colonic CD4 + T reg cells. T reg cells are known to play a role in balancing the immune activity of other CD4 + T cell subsets. Documented T reg cell activation by Clostridium spp. 8 and previous descriptions of tissue-specific transcriptional profiles 22 inspired us to interrogate these cells in greater detail. First, we noted that the relative proportion of T reg cells did not change significantly from proximal to distal colon ( Fig. 2c ). We then investigated whether the transcriptional profiles of T reg cells from different compartments indicated distinct activation states or functionalities. As observed previously in the mouse 22 , subclustering of T reg cells from the MLNs revealed major populations of central T reg cells and effector T reg cells ( Fig. 4a ). Central T reg cells were defined by the highest expression of SELL, while effector T reg cells were characterized by genes associated with the TNFRSF-NFκB pathway (TNFRSF9 and TNF; Supplementary Fig. 4a ). In addition, we observed a population previously termed nonlymphoid tissue-like T reg cells. These have the characteristics of nonlymphoid tissue T reg cells, including high expression of FOXP3, PRDM1, RORA, IL2RG, IL2RA and CTLA4 ( Fig. 4a and Supplementary Fig. 4a ). A fourth population, termed T reg -like cells, lacked the conventional markers of T reg cells-FOXP3 and IL2RA-but clustered more closely with T reg cells than conventional T cells ( Fig. 4a and Supplementary Fig. 4b ). These expressed the highest levels of PDCD1 (gene encoding PD-1) among T reg cell populations and, uniquely for this cell type, the transmembrane protein-encoding gene MS4A6A ( Supplementary Fig. 4a ). This population of T reg -like cells could represent a T reg population that transiently loses FOXP3 expression 23 .
In the colon, T reg cells clustered into three populations as described previously in the mouse ( Fig. 4a ) (ref. 22 ). KLRB1 + (also known as CD161) T reg cells were characterized by the expression of LAG3, IL2RA, CTLA4, KLRB1, ICOS and FOXP3 ( Supplementary  Fig. 4a ) suggesting a robust regulatory function, analogous to CD161 + T reg cells described in human colon tissue 24 . Nonlymphoid tissue T reg cells express IKZF2, GATA3 and DUSP4 ( Supplementary  Fig. 4a ), consistent with the profile of thymus-derived T reg cells 25 . The third population exhibited a profile reminiscent of lymphoid tissue T reg cells with expression of SELL, CCR7, TCR7, CXCR5 and RGS2, and were termed lymphoid tissue-like T reg cells ( Supplementary  Fig. 4a ). Lymphoid tissue-like T reg cells are probably newly arrived in the colon tissue from MLNs. A small number of MKI67 + T reg cells were also identified in the colon and MLNs ( Fig. 4a and Supplementary Table 3 ). The proportions of these subsets varied by donor but were mostly consistent between colonic regions (Fig. 4b) .
The presence of nonlymphoid tissue-like T reg cells in the MLNs and lymphoid tissue-like T reg cells in the colon, both with profiles suggesting migration, led us to recreate this migration pathway in silico. We ordered all T reg cells along 'pseudospace' using Monocle v.2.10.1. This gave rise to a smooth pseudospace trajectory from resting central T reg cells in the MLNs to highly regulatory T reg cells in the colon (Fig. 4c ). As seen in the mouse 22 , nonlymphoid tissue-like T reg cells and lymphoid tissue-like T reg cells blended in the middle of the trajectory, in accordance with these cells representing transitioning and migratory populations between lymphoid and peripheral tissues. To understand which gene signatures drive the migration and tissue adaptation of T reg cells in human tissues, we determined the genes changing along the previously calculated pseudospace (Fig. 4c) . Genes expressed at the beginning of pseudospace included SELL, CCR7 and CXCR4, which permit entry into lymph nodes ( Fig. 4c ). At the end of pseudospace, the most highly expressed genes were FOXP3, IL2RA, CTLA4, IL10 and LAG3.
These genes, which encode suppressive molecules, were coexpressed with tumor necrosis factor receptor (TNFR) genes (TNFRSF4, TNFRSF18, TNFRSF1B) indicating reliance on the TNFRSF-NFκB axis. Chemokine receptor-encoding genes CXCR3, CXCR6, CCR6 and CCR4 were also expressed by T reg cells in the periphery, matching previous reports of T H 1-and T H 17-like T reg cells in the colon ( Fig. 4c ) (ref. 22 ). Together, these results highlight heterogeneity in T reg cell states in the MLNs and colon and reveal a possible FOXP3-transiently absent population. We also infer a continuous activation trajectory of these T reg cell states between draining lymph nodes and colon, and highlight genes regulating T reg cell migration between tissues and their adoption of T H -like profiles.
B cells display a proximal-to-distal colon activation gradient.
Following from our observations in CD4 + T cells across the colon, we next focused on humoral responses by performing a more indepth analysis of B cells in different colonic regions. We compared transcriptional profiles of plasma cells between different colonic regions. This analysis revealed CCL3 and CCL4 as highly enriched in cecal plasma cells (log fold change = 0.61 and 0.70; adjusted P < 10 −28 and < 10 −9 , respectively; Fig. 5a ). These chemokine-encoding genes are expressed by B cells in response to B cell receptor (BCR) activation 26 and result in the migration of CCR5-expressing cells, such as T cells and monocytes 27 , to the tissue microenvironment. This suggests that BCR cross-linking and signaling may be more prominent in the proximal colon. Cecal plasma B cells were also enriched for CXCR4 (log fold change = 0.44; adjusted P < 10 −10 ) ( Fig. 5a ), which encodes a chemokine receptor highly expressed by germinal center B cells and important for the movement of plasmablasts to the germinal center-T zone interface post-germinal center responses 28 .
Among the genes more highly expressed by plasma cells in the sigmoid colon was CD27 ( Fig. 5a ; log fold change = 0.24; adjusted P < 10 −40 ), which encodes a member of the TNFR family that is expressed by memory B cells and even more highly by plasma cells 29 . We confirmed differential expression of CD27 protein and additionally observed a proximal-to-distal gradient of increasing CD27 expression by plasma cells in the colon (Fig. 5b ). Targeted homing of B cells from their site of activation in lymphoid tissues to the colonic lamina propria relies on signaling through CCR10, its cognate ligand CCL28 and integrin α 4 β 7 (ref. 30 ). CCR10 (log fold change = 0.24; adjusted P < 10 −16 ), ITGA4 (log fold change = 0.58; adjusted P < 10 −24 ) and ITGB4 (log fold change = 0.57; adjusted P < 10 −108 ) were also more highly expressed by sigmoid colon IgA + plasma cells ( Fig. 5a ).
To determine whether the B cell clonal repertoire changes across the colon, we took advantage of the paired single-cell VDJ sequencing data available from two donors for which scRNA-seq libraries were generated using 10x Genomics 5′ chemistry. We confirmed the expression of IgM and IgD isotypes by follicular B cells, IgG1 and IgG2 by IgG + plasma cells, IgA1 and IgM expression by memory cells in the MLNs and predominantly IgA2 expression by plasma cells of the colon (Fig. 5c ). The mutation frequency of the heavy chain variable region was greatest in the plasma cells followed by memory B cells, indicating more somatic hypermutation by these cell types compared to naive follicular B cells ( Fig. 5d ). Additionally, while mutational frequency was consistent across colonic regions and MLNs for memory and follicular B cells, it was significantly increased in IgA + plasma cells of the sigmoid colon compared to the other colonic regions (Fig. 5e ). IgG + plasma cells also showed a trend toward increased mutational frequency in the sigmoid colon; however, their numbers were limiting ( Fig. 5e ).
We then identified clonally related B cells to explore clonal expansion dynamics of different cellular populations throughout the gut. Clonal expansion was evident in memory B cells, and IgA + and IgG + plasma cells ( Fig. 5f ). While the relative abundance of clonal groups did not differ across the colonic regions of memory B cells and IgG + plasma cells, again this was greatest for IgA + plasma cells in the sigmoid colon ( Fig. 5f ). This was supported by bootstrapped VDJ sequence diversity analysis of clonally related IgA + plasma cells, which showed that the diversity of BCR sequences was consistent between donors and that there was a trend for decreased diversity (consistent with higher rates of clonal expansion) of IgA + plasma cells in the sigmoid colon ( Supplementary Fig. 5a,b ). Although some clones were shared between B cell types (that is, memory and IgA + plasma cells), indicating that alternate B cell fates can derive from a single precursor cell, most expanded clones within the gut were of the same cell type ( Supplementary Fig. 5c ). Finally, we found many examples of B cell clones shared between all three colonic regions, and to a lesser extent the MLNs, for both donors (Fig. 5g ), indicating dissemination of B cells throughout the colon as reported previously 31 . Our observation of B cell dissemination throughout the colon was replicated with bulk BCR sequencing (BCR-seq) from whole tissue (Fig. 5h ). Increased clonal variability of sigmoid colon B cells was reflected in a greater spread of BCR variable chains expressed compared with the cecum and transverse colon ( Supplementary Fig. 5d ), altogether suggesting a more active response in the distal versus proximal colon.
These data indicate a highly activated state of plasma cells in the distal colon compared with proximal colon plasma cells, characterized by greater accumulation, somatic hypermutation, clonal expansion and stronger homing to the colonic mucosa. IgA is responsive to a richer microbial community in the sigmoid colon. Previous reports have shown that IgA is secreted by plasma cells in response to the presence of specific bacterial species, rather than as a general response to the microbiome 32 . In light of this, we examined whether the increased plasma cell activation we observed in the sigmoid colon was linked to differences in bacterial XBP1  FTL  TNFRSF18  CD38  CCL3  CCL4  CXCR4  EGR1  ITGA4  ID3  CD53  CRIP1  ITGB7  CCR10  TNFRSF17 species. To this end, we assessed IgA opsonization of bacteria from the donor microbiome samples (Fig. 6a) . A greater proportion of bacteria from the sigmoid colon was positive for IgA binding compared with bacteria from the cecum and transverse colon (Fig. 6b ). Furthermore, shotgun sequencing of IgA-opsonized bacteria revealed a richer community of species in the sigmoid colon ( Fig. 6c and Supplementary Table 5 ). Diversity of IgA-bound bacteria, which considers relative abundance of each species, was lower in the sigmoid colon compared to cecum (Fig. 6d) . These data suggest that, compared with the cecum, IgA + plasma cells of the sigmoid colon respond to a rich and unevenly represented community of bacterial species, probably contributing to their increased activation status, strong homing to the colon and trend toward greater clonal diversity ( Supplementary Fig. 6 ).
Discussion
In this study, we performed the first simultaneous assessment of the colonic mucosal microbiome and immune cells in human donors at steady state. This enabled us to compare lymphoid and peripheral tissue immunity and explore how immune cells and their neighboring microbiome change along the colon within the same individuals. In doing so, we have highlighted previously unappreciated regional differences in both cellular communities. Our unique annotated colon immune single-cell dataset is available at the Gut Cell Atlas (https://www.gutcellatlas.org/), where users can visualize their genes of interest.
We describe a shift in the balance of subsets of helper T cells, with a predominance of T H 17 in the cecum and T H 1 in the sigmoid colon. Decreasing abundance of T H 17 cells has similarly been shown from the proximal small intestine to the colon in mice 5 . Additionally, the simultaneous increase of the genus Bacteroides and T H 1 numbers in the sigmoid colon are in line with findings that polysaccharide from Bacteroides fragilis preferentially induces T H 1 differentiation in the intestines of germ-free mice 9 . An alternative or complementary explanation for skewed helper T cell proportions and variation in transcriptional profiles is offered by Harbour et al. 33 , who demonstrated that T H 17 cells can give rise to an interferon-gamma + 'T H 1-like' cell in response to interleukin-23 production by innate cells. These findings demonstrate the complexity of external signals shaping colonic T H responses leading to regional changes in their numbers and differentiation.
In contrast to conventional T cells, T reg cells are evenly represented across the colon. T reg cell subpopulations within the MLNs and colonic tissue are analogous to those we recently described in the mouse 22 . We also identified an additional population, termed T reg -like cells, reminiscent of a CD25 − FOXP3 lo PD1 hi T reg population in the peripheral blood, although the latter was described to also express Ki67 (ref. 34 ). This population could represent uncommitted T reg cells experiencing transient loss of FOXP3 while retaining regulatory potential 23 or permanent loss of FOXP3 and adoption of a more proinflammatory phenotype after repeated stimulation 35 . Our pseudospace analysis of T reg cells suggests a continuum of activation states from resting cells in the lymphoid tissue through to highly suppressive cells in the periphery. We identified genes underlying this transition, including chemokine receptors that are strongly expressed on arrival at the intestines and enable interaction with, and suppression of, T H 1 and T H 17 cells 36 . Similarly to the mouse, pseudospace from lymphoid to peripheral tissue correlates with transcriptional markers of migratory potential and suppression of effector cells. We found that IgA + plasma cells are more abundant and have greater expression of colon-specific migration markers (CCR10, ITGA4 and ITGB7) in the sigmoid colon compared to the proximal colon. This adds finer resolution to previous reports describing increasing abundance of IgA + plasma cells from the small intestine to the colon 37 . Our B cell repertoire analysis demonstrates extensive clonal expansion within each colonic region and to a lesser extent between regions, arguing for colonic dissemination of B cells from the same precursor pool, followed by local expansion. Furthermore, more clonal sharing existed between regions of the colon than with MLNs, consistent with recent work showing that while MLN clones can also be detected in blood, the intestines are host to a unique B cell clonal network 38 . Sigmoid colon plasma cells exhibit greater mutational abundance and clonal expansion. This is consistent with a trend toward reduced plasma cell clonal diversity in the sigmoid colon. While this was not statistically significant, it may have been due to the relatively low number of VDJ sequences obtained from these samples, thus decreasing the power of this analysis. Previous work has shown that the mutational frequency of B cells is consistently high between duodenum and colon and are primarily driven by dietary and microbiome antigens, respectively 39 . Thus, we suggest that enhanced plasma cell accumulation, mutation and expansion in the sigmoid colon is in response to continued stimulation from the local microbiome. This may happen through increased engagement of sigmoid colon plasma cells in T cell-mediated germinal center reactions in gut-associated lymphoid structures or in T cell-independent somatic hypermutation in local isolated lymphoid follicles 40 followed by local expansion. The exact mechanisms require further study.
Finally, we showed greater IgA binding to the microbiome in the sigmoid colon compared to proximal sites. One possible explanation for this observation is the accumulation of upstream secreted IgA and IgA-bound bacteria in the sigmoid colon. However, our simultaneous observation of enhanced plasma cell responses in the sigmoid colon suggests that IgA is locally produced as a result of immune poising. Possible scenarios contributing to a richer immune-reactive microbiome in the sigmoid colon are bacteria derived externally via the rectum. Alternatively, environmental pressures (that is, lower water and nutrient levels 2 ) could restrict outgrowth of dominant gastrointestinal species of the proximal colon, providing space for smaller communities of opportunistic species. The IgA response in the colon is antigen-specific rather than a general response to the presence of bacteria 32 . Thus, the overall increased number of unique species recognized by host IgA antibodies in the sigmoid colon fits with the enhanced clonal expansion and mutation of plasma cells at this site.
Together, our simultaneous analyses of the microbiome and neighboring immune cells highlight the significance of environmental signals in shaping and maintaining regional adaptive immune cell composition and function in the intestines at steady state.
Dysregulation of helper T cells 41 and plasma cells 42 has been implicated in susceptibility to inflammatory bowel disease. Observations of the linked compartmentalization of these immune cells and microbial species along the colon at steady state may provide a platform for understanding the mechanisms underpinning the tropism of different intestinal diseases to specific regions of the gut, such as Crohn's disease and ulcerative colitis.
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Methods
Colon and MLN tissue retrieval. Human tissue was obtained from deceased transplant organ donors after ethical approval (reference 15/EE/0152, East of England-Cambridge South Research Ethics Committee) and informed consent from the donor families. Fresh mucosal tissue from the cecum, transverse colon and sigmoid colon, and lymph nodes from the intestinal mesentery, were excised within 60 min of circulatory arrest; colon tissue was preserved in University of Wisconsin organ-preservation solution (Belzer UW Cold Storage Solution; Bridge to Life) and MLNs were stored in saline at 4 °C until processing. Tissue dissociation was conducted within 2 h of tissue retrieval. Four individuals (287c, 296b, 403c and 411c) had received antibiotics in the two weeks before death ( Supplementary Table 1 ).
Tissue dissociation for flow-sorting separation and magnetic-activated cell sorting (MACS) separation. Tissue pieces from donors 290b, 298c, 302c, 364b and 411c were manually diced and transferred into 5 mM of EDTA (Thermo Fisher Scientific), 1 mM of dithiothreitol (DTT; Sigma-Aldrich),10 mM of HEPES (Thermo Fisher Scientific), 2% FCS in Roswell Park Memorial Institute (RPMI) medium and incubated in a shaker (approximately 200 r.p.m.) for 20 min at 37 °C. Samples were briefly vortexed before the media were renewed and incubation was repeated. Tissue pieces were washed with 10 mM HEPES in PBS and transferred into 0.42 mg ml −1 of Liberase TL (Roche), 0.125 kU of DNase1 (Sigma-Aldrich),10 mM HEPES in RPMI; they were incubated for 30 min at 37 °C. The digested samples were passed through a 40 µm strainer and washed through with FCS/PBS.
Flow-sorting.
Cells from donor 290b, 298c and 302c were pelleted and resuspended in 40% Percoll (GE Healthcare Life Sciences). This was underlaid with 80% Percoll and centrifuged at 600g for 20 min with minimal acceleration and break. Cells at the interface were collected and washed with PBS. Cells were stained for fluorescence cytometry using the following (sourced from BioLegend unless otherwise stated): Zombie Aqua Fixable Viability Kit (1:200 dilution; catalog no. 423101); Brilliant Violet 650 anti-human CD45 (clone HI30; 1:100 dilution; catalog no. 304043); FITC anti-human CD3 (clone OKT3; 1:100 dilution; catalog no. 317305); Brilliant Violet 421 anti-human CD4 (clone SK3; 1:100 dilution; catalog no. 344631); PE/Cy7 anti-human CD8 (clone SK1; 1:100 dilution; catalog no. 344711); APC/Cyanine7 anti-human CD19 (clone HIB19; 1:100 dilution; catalog no. 302217); PerCP/Cyanine5.5 anti-human IgD (clone IA6-2; 1:100 dilution; catalog no. 348207); Brilliant Violet 711 anti-human CD27 (clone M-T271; 1:100 dilution; catalog no. 356429); Brilliant Violet 785 anti-human HLA-DR (clone L243; 1:100 dilution; catalog no. 307641); APC anti-human CD14 (clone 63D3; 1:100 dilution; catalog no. 367117); and CD11c monoclonal antibody (3.9), PE (clone 3.9; 1:100 dilution; catalog no. 12-0116-42; eBioscience). Non-CD4 + immune T cells were sorted as live singlet CD45 + , CD3 − and CD4 − . CD4 + T cells were sorted as live singlet CD45 + , CD3 + and CD4 + . Each fraction was manually counted using 0.4% Trypan Blue Solution (Gibco) and a hemocytometer and diluted to 500 cells µl −1 in PBS. Sorting was carried out on a BD FACSAria Fusion. Analysis of flow-sorting data was conducted with the FlowJo software v.10.4.
MACS cell enrichment.
Cells from donor 411c were pelleted for 5 min at 300g and resuspended in 80 µl of ice-cold MACS buffer (0.5% BSA (Sigma-Aldrich), 2 mM EDTA (Thermo Fisher Scientific) in Dulbecco's phosphate-buffered saline (DPBS; Gibco)) and 20 µl of CD45 MicroBeads (Miltenyi Biotec). Cells were incubated for 15 min at 4 °C before being washed with 2 ml of MACS buffer and centrifuged as stated earlier. Cells were resuspended in 500 µl of MACS buffer and passed through a pre-wetted mass spectrometry column on a QuadroMACS magnetic cell separator (Miltenyi Biotec). The column was washed 4 times with 500 µl of MACS buffer, allowing the full volume of each wash to pass through the column before the next wash. The column was removed from the magnet and cells were eluted with force with 1 ml of MACS buffer into a 15 ml tube. Cells were pelleted as stated earlier; cell number and viability were determined using a NucleoCounter NC-200 and Via1-Cassette (ChemoMetec). Cells were resuspended at 500 cells µl −1 in 0.04% BSA in PBS.
Tissue dissociation for Ficoll separation. The tissues from donor 390c were manually diced and <5.0 g was added per Miltenyi C tube (Miltenyi Biotec) with 5 ml tissue dissociation media (1× Liberase TL (0.13 U ml −1 DNase; Roche) and Benzonase Nuclease (10 U ml −1 ; Merck Millipore) in 1% FCS and 20 mM HEPES in PBS (Lonza)). Samples were dissociated with a gentleMACS Octo (Miltenyi Biotec) for a 30 min homogenizing, 37 °C cycle. Enzymatic digestion was stopped by adding 2 mM of EDTA in tissue dissociation media. Digested samples were then passed through a 70 µM SmartStrainer (Miltenyi Biotec) before being washed with PBS and pelleted at 500g for 10 min. Cells were resuspended in PBS, layered onto Ficoll-Paque PLUS (GE Healthcare Life Sciences) and spun at 400g for 25 min at room temperature. Mononuclear cells were retrieved from the Ficoll layer and washed with PBS. Cells were filtered through a 0.2 µM filter (Flowmi cell strainer; Bel-Art). Cells were manually counted using a hemocytometer and diluted to a concentration of 1,000 cells µl −1 in 0.04% BSA in PBS.
10x Genomics Chromium GEX library preparation and sequencing. Cells were loaded according to the manufacturer's protocol for the Chromium Single Cell 3′ Kit v.2 or 5′ gene expression v.2 to attain between 2,000 and 5,000 cells per well. Library preparation was carried out according to the manufacturer's protocol. For the samples from donors 290b, 298c and 302c, eight 10x Genomics Chromium 3′ libraries were pooled and sequenced on 8 lanes of an Illumina Hiseq 4000. For the samples from donors 390c and 417c, 16 10x Genomics Chromium 5′ libraries were pooled and sequenced on 2 lanes of a S2 flow cell of an Illumina NovaSeq 6000 with 50 base pairs paired-end reads.
10x Genomics Chromium VDJ library preparation and sequencing. 10x Genomics VDJ libraries were generated from the 5′ 10x Genomics Chromium complementary DNA (cDNA) libraries as detailed in the manufacturer's protocol. BCR libraries for each sample were pooled and sequenced on a single lane of an Illumina HiSeq 4000 with 150 bp paired-end reads.
Plate-based scRNA-seq. Plate-based scRNA-seq was performed with the NEBNext Single Cell/Low Input RNA Library Prep Kit for Illumina (catalog no. E6420L; New England Biolabs). Cells from donor 364b were snap-frozen in 10% dimethylsulfoxide in 90% BSA. Cells were thawed rapidly in a 37 °C water bath and diluted slowly with pre-warmed 2% FCS in DPBS. Cells were pelleted for 5 min at 300g and washed with 500 µl of DPBS and pelleted as before. BioLegend) and Zombie Aqua Fixable Viability Kit (1:400 dilution) and incubated for 30 min in the dark at room temperature. Cells were washed twice with 500 µl of 2% FCS in DPBS before being filtered through a 100 µM filter. Single, live, TCRβ + cells were FACS sorted into a preprepared 384-well plate (catalog no. 0030128508; Eppendorf) containing 2 µl of 1× NEBNext Cell Lysis Buffer (New England Biolabs). FACS sorting was performed with a BD Influx sorter (BD Biosciences) with the indexing setting enabled. Plates were sealed and spun at 100g for 1 min then immediately frozen on dry ice and stored at −80 °C.
cDNA generation was then performed in an automated manner on the Bravo NGS Workstation (Agilent Technologies). Briefly, 1.6 µl of Single Cell RT Primer Mix (New England Biolabs) was added to each well and annealed on a PCR machine (Peltier Thermal Cycler; MJ Research) at 70 °C for 5 min; 4.4 µl of reverse transcription mix was added to the mixture and further incubated at 42 °C for 90 min followed by 70 °C for 10 min to generate cDNA. Twenty-two microliters of cDNA amplification mix containing NEBNext Single Cell cDNA PCR MasterMix and PCR primer was mixed with the cDNA, sealed and spun at 100g for 1 min. cDNA amplification was then performed on a PCR machine (Peltier Thermal Cycler) at 98 °C for 45 s, 20 cycles of (98 °C for 10 s, 62 °C for 15 s, 72 °C for 3 min) and 72 °C for 5 min. The 384-well plate containing the amplified cDNA was purified with an AMPure XP workflow (catalog no. A63880; Beckman Coulter) and quantified with the AccuClear Ultra High Sensitivity dsDNA Quantitation Kit (catalog no. 31028; Biotium). Approximately 10 ng of cDNA was stamped into a fresh 384-well plate for sequencing library preparation.
Sequencing libraries were then generated on the Bravo NGS Workstation. Purified cDNA was fragmented by the addition of 0.8 µl of NEBNext Ultra II FS Enzyme Mix (New England Biolabs) and 2.8 µl of NEBNext Ultra II FS Reaction Buffer (New England Biolabs) to each well and incubated on a PCR machine (Peltier Thermal Cycler) at 72 °C for 15 min and 65 °C for 30 min. A ligation mixture was then prepared containing NEBNext Ultra II Ligation Master Mix (New England Biolabs), NEBNext Ligation Enhancer (New England Biolabs) and 100 µM Illumina-compatible adapters (Integrated DNA Technologies); 13.4 µl was added to each well of the 384-well plate. The ligation reaction was incubated on the Bravo NGS Workstation at 20 °C for 15 min and then purified and size-selected with an AMPure XP workflow. Twenty microliters of KAPA HiFi HotStart ReadyMix (catalog no. 07958927001; Roche) was then added to a preprepared 384-well plate containing 100 µM of i5 and i7 indexing primer mix (50 µM each; Integrated DNA Technologies). The indexing primer pairs were unique to allow multiplexing of up to 384 single cells in 1 sequencing pool. The plate containing the PCR Master Mix and indexing primers was stamped onto the adapter-ligated purified cDNA, then sealed and spun at 100g for 1 min. Amplification was performed on a PCR machine (Peltier Thermal Cycler) at 95 °C for 5 min, 8 cycles of (98 °C for 30 s, 65 °C for 30 s, 72 °C for 1 min) and 72 °C for 5 min. The PCR products were pooled in equal volumes on the Microlab STAR Automated Liquid Handler (Hamilton Robotics); the pool was purified and size-selected with an AMPure XP workflow. scRNA-seq quality control. Single-cell read counts from all samples were pooled and filtered considering the number of unique molecular identifiers, keeping genes expressed in a minimum of 3 cells and cells where genes detected were in the 700-6,000 range. Nonimmune cells were excluded from the final analysis based on the absence of receptor-type tyrosine-protein phosphatase C and the presence of markers such as epithelial cell adhesion molecule (epithelial cells) and collagen alpha-1(I) chain (fibroblasts).
Cell-type annotation. Cells were clustered using the Scanpy v.1.4 processing pipeline 43 . Briefly, counts were normalized to 10,000 reads per cell (sc.pp.normalise_per_cell) and log-transformed (sc.pp.log1p) to be comparable among cells. The number of unique molecular identifiers and percentage of mitochondrial genes were regressed out (sc.pp.regress_out) and genes were scaled (sc.pp.scale) to unit variance. Normalized counts were used to detect highly variable genes (sc.pp.highly_variable_genes). Batch correction between donors was performed using bbknn v.1.3.6 (ref. 44 ) on 50 principal components and the trim parameter set to 100. Clusters were then identified using Leiden graph-based clustering (resolution set to 1). Cell identity was assigned using the known markers shown in Fig. 2b ; the top differentially expressed genes were identified using a Wilcoxon rank-sum test (sc.tl.rank_genes_groups function; Supplementary Table 4 ). CD4 T cells, myeloid cells and B cells were subclustered for identification of subsets within each cluster. Annotated T reg cells were further subclustered using the 'FindClusters' and 'RunUMAP' functions from Seurat v.3.0.1 (ref. 45 ) (Fig. 4) . The number of principal components used for T reg cell clustering were estimated by the elbow of a principal component analysis screen plot, combined with manual exploration of the top genes from each principal component. Clustering of MLN T reg cells was performed using 1-14 principal components and a resolution of 0.3; clustering of colonic T reg cells was performed with 1-11 principal components and a resolution of 0.3.
'Pseudospace' analysis. 'Pseudospace' analysis of T reg cells was performed using
Monocle v.2.10.1 (ref. 46 ). Data were log-normalized and cell-ordered based on DDRTree reduction on highly variable genes with donor effect regression. The heatmap in Fig. 4c was generated using the 'plot_pseudotime_heatmap' function in Monocle v.2.10.1 (ref. 46 ). Genes contributing to 'pseudospace' were first filtered for exclusion of mitochondria and Ig genes, expression in at least 15 cells and q < 0.001. Gene expression was smoothed into 100 bins along pseudospace using a natural spline with 3 d.f. Matching column annotation for each bin was determined as the most prevalent tissue region origin of the cells within that bin. Genes were grouped into two clusters and ordered by hierarchical clustering. Cells were ordered through pseudotime.
Sampling of microbiome. Swabs were taken immediate of the mucosal surface of excised tissue using Transwab Cary Blair (catalog no. MW168; MW). Swabs were maintained at 4 °C. Working in a biosafety cabinet, swabs were washed in 500 µl of anaerobic PBS and mixed with anaerobic 50% glycerol before being snap-frozen on dry ice and stored at −80 °C until use.
Microbiota profiling and sequencing. The microbiota vials were defrosted on ice. Approximately 100 µl of each was transferred into new Eppendorf tubes. DNA was extracted from the microbiome samples using the FastDNA Spin Kit for Soil (catalog no. 116560200; MP Biomedicals). 16S rRNA gene amplicon libraries were made by PCR amplification of variable regions 1 and 2 of the 16S rRNA gene using the Q5 High-Fidelity Polymerase Kit (New England Biolabs) as described in Browne et al. 47 . Primers 27F-AATGATACGGCGACCACCGAGATCTACAC (first part, Illumina adapter), TATGGTAATT (second part, forward primer pad), CC (third part, forward primer linker) AGMGTTYGATYMTGGCTCAG (fourth part, forward primer)-and 338R-CAAGCAGAAGACGGCATACGAGAT (first part, reverse complement of 3′ Illumina adapter), ACGAGACTGATT (second part, golay barcode), AGTCAGTCAG (third part, reverse primer pad), AA (fourth part, reverse primer linker) GCTGCCTCCCGTAGGAGT (fifth part, reverse primer)-were used. Four PCR amplification reactions per sample were carried out; products were pooled and combined in equimolar amounts for sequencing with the Illumina MiSeq platform, generating 150 bp reads. Analysis of partial 16S rRNA sequences was carried out using SILVA v.132 and mothur MiSeq SOP v.1.42.3 (ref. 48 ). The 16S rRNA gene alignments were used to determine a maximum likelihood phylogeny using FastTree v.2.1.10 (ref. 49 ). Phylogenetic trees were visualized and edited using iTOL v.5 (ref. 50 ).
T cell clonal sharing analysis. T cell receptor sequences generated using the Smart-Seq2 scRNA-seq protocol were reconstructed using the TraCeR software (https://hub.docker.com/r/teichlab/tracer/) as described previously 51 .
Bulk BCR-seq. Small portions of samples were taken from excised tissues and snap-frozen in 1 ml of RNAlater (Ambion). RNA was extracted from tissue using QIAshredder and the QIAGEN Mini Kit (QIAGEN). RNA concentration was measured using an Agilent bioanalyzer (Agilent Technologies). BCR heavy chain sequences of all B lineage subsets present in the tissue were amplified as described previously 52 . Briefly, RNA was reverse-transcribed using a barcoded reverse primer set capturing all antibody (sub)classes. Targeted heavy chain amplification was performed with a multiplex set of IGHV gene primers to the FR1 region and a universal reverse primer using HiFi quantitative PCR (KAPA Biosystems). After adapter filtering and trimming, BCR sequences were assembled and aligned using MiXCR v.3.0.1 (ref. 53 ). It is worth noting that detected BCR sequences are biased toward those included in the reference database; while there is a continuous discovery of germline alleles, no database is currently a complete reflection of the human Ig heavy locus (IgH) diversity. Only in-frame and IgH sequences with at least three read counts were kept for the analysis. tcR v.2.2.1 was used to calculate the CDR3 nucleotide shared repertoire 54 .
10x Genomics single-cell VDJ data processing, quality control and annotation. Poor-quality VDJ contigs that either did not map to Ig chains or were assigned incomplete by cellranger vdj v.3.1.0 were discarded. For additional processing, all IgH sequence contigs per donor were combined. We further filtered IgH contigs as to whether they had sufficient coverage of constant regions to ensure accurate isotype assignment between closely related subclasses using MaskPrimers.py (pRESTO v.0.5.10) (ref. 55 ). IgH sequences were then further annotated using IgBLAST v.1.12.0 (ref. 56 ) and reassigned isotype classes using AssignGenes.py (pRESTO) before correction of ambiguous V gene assignments using TIgGER v.03.1 (ref. 57 ). Clonally related IgH sequences were identified using DefineClones. py (ChangeO v.0.4.5) (ref. 57 ) with a nearest neighbor distance threshold of 0.2, as determined by visual inspection of the output of distToNearest (Shazam v.0.1.11) (ref. 57 ). CreateGermlines.py (ChangeO v.0.4.5) was then used to infer germline sequences for each clonal family; observedMutations (Shazam v.0.1.11) was used to calculate somatic hypermutation frequencies for each IgH contig. Estimated clonal abundances and IgH diversity analyses within each donor were performed using the estimateAbundance, rarefyDiversity and testDiversity functions of Alakazam v.0.2.11 (ref. 57 ) with a bootstrap number of 500. Finally, the number of qualityfiltered and annotated IgH, IgK or IgL chains were determined per unique cell barcode. If more than one contig per chain was identified, the metadata for that cell was ascribed as 'Multi' . The subsequent metadata table was then integrated with the scRNA-seq gene expression objects for annotation of IgH contigs with B cell types and downstream analysis. Co-occurrence of expanded clone members between tissues and/or cell types was reported as a binary event for each clone that contained a member within two different tissues and/or cell types.
Quantifying IgA binding of bacteria. Microbiome frozen in 50% glycerol was defrosted on ice before being washed in PBS and pelleted for 3 min at 8,000 r.p.m. Bacteria were then stained on ice for 30 min with PE anti-human IgG Fc (clone HP6017; 1:100 dilution; catalog no. 409304; BioLegend), Biotin mouse anti-human IgA1/IgA2 (clone G20-359; 1:50 dilution; catalog no. 555884; BD), followed by 20 min with APC Streptavidin (1:100 dilution; catalog no. 405207; BioLegend). For the isotype controls, Biotin Mouse IgG1 κ Isotype Control (1:50 dilution; catalog no. 550615; BD) or PE Mouse IgG2a, κ Isotype Ctrl (1:100 dilution; catalog no. 400212; BioLegend) were used. Bacteria were washed before and after DNA was stained with Hoechst 33342 (Sigma-Aldrich). Stained bacteria were sorted as Hoechst + and IgG + IgA + or IgG − IgA + in PBS using the BD Influx cell sorter (BD Biosciences) and then stored at −80 °C until DNA extraction.
Genomic DNA extraction for shotgun sequencing of IgA-bound bacteria. Bacteria in PBS were defrosted on ice before being pelleted at 3,900 r.p.m. for 5 min at 4 °C. The supernatant was removed and the pellet resuspended in 2 ml of 25% sucrose in Tris-EDTA buffer (10 mM of Tris (PanReac AppliChem), pH8, and 1 mM of EDTA (Invitrogen), pH8); 50 µl of 100 mg ml −1 lysozyme (Roche) in 0.25 M of Tris was added and incubated at 37 °C for 1 h. Onehundred microliters of proteinase K (18 mg ml −1 )(QIAGEN),15 µl of RNAase A (20 mg ml −1 )(Invitrogen), 400 µl of 0.5 M EDTA (pH 8) and 250 µl of 10% sodium lauroyl sarcosinate (Sigma) were then added. This was left on ice for 2 h and then incubated at 50 °C overnight. The DNA was then mixed with 5 ml of Tris-EDTA buffer and purified using four cycles of addition of 5 ml phenol:chlorophorm:isoamyl alcohol in 15 ml MaXtract High Density Phase Lock Gel (PLG) tubes (QIAGEN), centrifuging at 2,800 r.p.m. for 5 min and retreiving the aqueous phase into a new PLG tube. DNA in the final aqueous phase was precipitated with 10 ml of 100% ethanol at −20 °C overnight, centrifuged at 3,900 r.p.m. for 20 min at 4 °C and washed with 10 ml of 70% ethanol, before being centrifuged at 4,500 r.p.m. for 10 min at 4 °C and gently dried at 50 °C overnight. DNA was then resuspended in 200 µl of Tris-EDTA buffer and isolated by running through a gel. Samples were quantitated by using a Qubit 2.0 Fluorometer and dsDNA HS Assay Kit (Thermo Fisher Scientific) and then pooled. Pooled DNA was sequenced on the HiSeq 2500 platform (Illumina). The inverse Simpson (diversity) and chao (richness) of IgA-opsonized bacteria was determined using the R package 'microbiome' . Corresponding author(s): Kylie James, Sarah Teichmann Last updated by author(s): Jan 9, 2020 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
